Revolution Medicines · 2 months ago
Senior Manager, Data Product Owner, Market Access
Redwood City, California, United States
Full-time
Onsite
Senior Level
$158K/yr - $198K/yr
5+ years expRevolution Medicines is a clinical-stage precision oncology company focused on developing novel targeted therapies for RAS-addicted cancers. They are seeking a Senior Manager, Data Product Owner for Market Access to support the Commercial team by integrating and delivering actionable insights from critical data. This role involves defining product vision, managing the data product roadmap, and ensuring compliance with healthcare data standards.
Health CareLife ScienceMedical
Responsibilities
Define and manage the data product roadmap across Market Access, Patient Services, and Distribution to support commercial launch
Translate complex commercial workflows (payer contracting, hub services, SP/SD distribution) into clear, prioritized user stories and requirements
Troubleshoot data issues and continuously improve processes to maintain performant systems and high data quality
Partner with external vendors (hub providers, specialty pharmacies/distributors, data aggregators) to ensure timely and accurate data feeds are ingested into our platform
Oversee integration of Market Access data, including areas such as: Hub and SP data: Benefits Verification, (BV), Prior Authorization (PA), appeals, conversion, time-to-fill, abandonment, and status reporting. Dispensing and Inventory data. Order and Sales data
Support technical infrastructure for dashboards and analytics that provide visibility into: Payer coverage and restrictions. Patient journey and onboarding metrics. Copay program utilization and ROI. Channel inventory and product availability
Ensure data governance, privacy, and compliance with HIPAA, GxP, and industry regulations
Collaborate with Market Access, Channel & Distribution, Patient Services, and Finance leaders to ensure data supports payer negotiations, access strategy, and gross-to-net reporting
Support data and related actions for QBRs with HUB and Specialty Pharmacy partners
Champion agile product management best practices, driving adoption and continuous improvement across teams
Manage and/or mentor junior staff
Qualification
Required
Bachelor's degree (or equivalent experience) in business, computer science, information systems, or related field
Strong collaborator with cross-functional teams (Market Access, Patient Services, Channel/Distribution, Finance, IT)
Proven experience translating commercial business needs into technical data products
5+ years in a Product Owner or Technical Product Manager, or Commercial Data role, with 9+ years in pharma/biotech
Deep knowledge of: Payer formulary/coverage data (e.g., MMIT, Fingertip, IQVIA)
Hub and patient services data (BV, PA, adherence, copay/bridge programs)
Specialty pharmacy/distributor data standards, including EDI 852, 867, 844/849
Oncology launch experience with familiarity in unique access barriers (restricted distribution, step edits, high PA burden)
Strong understanding of HIPAA, patient privacy, and compliance requirements
Preferred
Understanding of gross-to-net drivers (rebates, chargebacks, distribution fees)
Experience managing third-party vendors and data partners
Agile/Scrum certification (CSPO, PSPO) or equivalent
Comfort operating in a fast-paced, emerging pharma environment
Benefits
Competitive cash compensation
Robust equity awards
Strong benefits
Significant learning and development opportunities
Company
Revolution Medicines
Revolution Medicines is an innovative and dynamic organization of expert biologists, chemists, pharmacologists, clinical scientists.
501-1000 employees
H1B Sponsorship
Revolution Medicines has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (13)
2024 (18)
2023 (15)
2022 (8)
2021 (1)
2020 (2)
Funding
Current Stage
Public CompanyTotal Funding
$2.25BKey Investors
Royalty PharmaBoxer CapitalNextech Invest
2025-06-24Post Ipo Debt· $250M
2024-12-02Post Ipo Equity· $750M
2023-03-02Post Ipo Equity· $323.6M
Leadership Team
Luan Wilfong
Chief Human Resources Officer
Steve Kelsey
President
Recent News
Pharmaceutical Technology
2026-01-13
Company data provided by crunchbase